172 related articles for article (PubMed ID: 20454923)
1. RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects.
Sun H; Bai J; Chen F; Jin Y; Yu Y; Jin L; Fu S
Breast Cancer Res Treat; 2011 Jan; 125(1):157-61. PubMed ID: 20454923
[TBL] [Abstract][Full Text] [Related]
2. Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk.
Lu PH; Li C; Zhou HY; Wang T; Chu CQ; Shen W; Tao GQ
Breast Cancer Res Treat; 2011 Jan; 125(1):299-300. PubMed ID: 20878355
[No Abstract] [Full Text] [Related]
3. Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects.
Sun H; Bai J; Chen F; Jin Y; Yu Y; Fu S
Breast Cancer Res Treat; 2011 Jan; 125(1):175-9. PubMed ID: 20464476
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.
Zhao M; Chen P; Dong Y; Zhu X; Zhang X
PLoS One; 2014; 9(1):e87259. PubMed ID: 24475258
[TBL] [Abstract][Full Text] [Related]
5. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
6. RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
Zhou GW; Hu J; Peng XD; Li Q
Breast Cancer Res Treat; 2011 Jan; 125(2):529-35. PubMed ID: 20623332
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
8. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D; Pooja S; Kumar S; Rajender S
Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
[TBL] [Abstract][Full Text] [Related]
9. MTRR A66G polymorphism and breast cancer risk: a meta-analysis.
Hu J; Zhou GW; Wang N; Wang YJ
Breast Cancer Res Treat; 2010 Dec; 124(3):779-84. PubMed ID: 20411324
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
11. No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects.
Alqumber MA; Dar SA; Haque S; Wahid M; Singh R; Akhter N
Asian Pac J Cancer Prev; 2014; 15(20):8725-34. PubMed ID: 25374198
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects.
Lu S; Wang Z; Cui D; Liu H; Hao X
Breast Cancer Res Treat; 2011 Jan; 125(1):253-9. PubMed ID: 20526737
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1 Polymorphism and Breast Cancer Risk: a Meta-Analysis in the Chinese Population.
Xue CX; He XM; Zou DH
Clin Lab; 2016 Nov; 62(11):2277-2284. PubMed ID: 28164656
[TBL] [Abstract][Full Text] [Related]
15. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
[TBL] [Abstract][Full Text] [Related]
17. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
19. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
20. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
